Oue Lippo Healthcare Ltd
SGX:5WA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.025
0.031
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 5WA stock under the Base Case scenario is 0.088 SGD. Compared to the current market price of 0.027 SGD, Oue Lippo Healthcare Ltd is Undervalued by 69%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Oue Lippo Healthcare Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for 5WA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Oue Lippo Healthcare Ltd
Balance Sheet Decomposition
Oue Lippo Healthcare Ltd
Current Assets | 119.9m |
Cash & Short-Term Investments | 56.7m |
Receivables | 26.8m |
Other Current Assets | 36.3m |
Non-Current Assets | 1.3B |
Long-Term Investments | 1.2B |
PP&E | 8m |
Intangibles | 30.8m |
Other Non-Current Assets | 3.2m |
Current Liabilities | 105.6m |
Accounts Payable | 48.4m |
Other Current Liabilities | 57.2m |
Non-Current Liabilities | 1B |
Long-Term Debt | 513.8m |
Other Non-Current Liabilities | 507.8m |
Earnings Waterfall
Oue Lippo Healthcare Ltd
Revenue
|
155.5m
SGD
|
Cost of Revenue
|
-36.6m
SGD
|
Gross Profit
|
118.9m
SGD
|
Operating Expenses
|
-28.4m
SGD
|
Operating Income
|
90.5m
SGD
|
Other Expenses
|
-88m
SGD
|
Net Income
|
2.4m
SGD
|
Free Cash Flow Analysis
Oue Lippo Healthcare Ltd
SGD | |
Free Cash Flow | SGD |
5WA Profitability Score
Profitability Due Diligence
Oue Lippo Healthcare Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Oue Lippo Healthcare Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
5WA Solvency Score
Solvency Due Diligence
Oue Lippo Healthcare Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Oue Lippo Healthcare Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
5WA Price Targets Summary
Oue Lippo Healthcare Ltd
Dividends
Current shareholder yield for 5WA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
OUE Lippo Healthcare Ltd. is as an investment holding company, which engages in the provision of healthcare services and facilities. The firm owns, operates and invests in healthcare businesses Asian markets. The Company’s segments include Healthcare operations, Healthcare assets, Properties under development and Investments. The Healthcare Operations segment includes the operation of hospitals and trading of pharmaceutical supplies and drugs and has operations in China and Myanmar. The Properties under development segment includes development of medical facilities, healthcare-related assets and integrated mixed-used projects and has development properties in China and Malaysia. The Healthcare assets segment includes rental of investment properties and assets owned by the Company and has assets in Japan and China. The Investments segment has investments in real estate investment trust (REIT) and REIT manager. OUELH also holds a 50% equity interest in China Merchants Lippo Hospital Management (Shenzhen) Limited (CM Lippo).
Officers
The intrinsic value of one 5WA stock under the Base Case scenario is 0.088 SGD.
Compared to the current market price of 0.027 SGD, Oue Lippo Healthcare Ltd is Undervalued by 69%.